Discover Tenders by Profile Sections Sector

Find the most relevant tenders for Profile Sections. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Profile Sections tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Profile Sections tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Dimethyl Fumarate

Deadline: 10 May 2026

Germany

Ref. No.: 7526115

EMD:Ref Document

Bid Value: Ref Document

12 Days Left

Open House Contracts 2024 3

Deadline: 29 Oct 2026

Germany

Ref. No.: 7525827

EMD:Ref Document

Bid Value: Ref Document

184 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Chlorthalidone In The Dosage Form Tab

Deadline: 10 May 2026

Germany

Ref. No.: 7512094

EMD:Ref Document

Bid Value: Ref Document

12 Days Left

Open House Original Rebate Agreements 2024 08 Fluticasone Vilanterol Active Ingredient Combination

Deadline: 30 Sep 2026

Germany

Ref. No.: 7490491

EMD:Ref Document

Bid Value: Ref Document

155 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Testosterone Enanthate Undecanoate In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 7485133

EMD:Ref Document

Bid Value: Ref Document

12 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Codeine In The Dosage Form Tei

Deadline: 10 May 2026

Germany

Ref. No.: 7484008

EMD:Ref Document

Bid Value: Ref Document

12 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 7438230

EMD:Ref Document

Bid Value: Ref Document

247 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 7326193

EMD:Ref Document

Bid Value: Ref Document

410 Days Left

Open House Discount Agreements 2024 04 Rivaroxaban

Deadline: 30 Apr 2026

Germany

Ref. No.: 7280704

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Devcom Army Research Laboratory Broad Agency Announcement For Foundational Research

Deadline: 20 Nov 2027

United States

Ref. No.: 7268638

EMD:Ref Document

Bid Value: Ref Document

571 Days Left

Open House Original Discount Agreements 2024 07 Dapagliflozin

Deadline: 31 Aug 2026

Germany

Ref. No.: 7262307

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dupilumab D11Ah05 Within The Framework Of A So Called Open House Model

Deadline: 30 Jun 2026

Germany

Ref. No.: 7238860

EMD:Ref Document

Bid Value: Ref Document

63 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Brinzolamide Brimonidine Atc S01Ec24 For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7238843

EMD:Ref Document

Bid Value: Ref Document

68 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Midazolam N05Cd08 Within The Framework Of A So Called Open House Model

Deadline: 30 Jun 2026

Germany

Ref. No.: 7238402

EMD:Ref Document

Bid Value: Ref Document

63 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 30 Jun 2026

Germany

Ref. No.: 7235672

EMD:Ref Document

Bid Value: Ref Document

63 Days Left

Showing 29551 to 29565 of 29916 results

‹
1
2
...
1968
1969
1970
1971
1972
1973
1974
...
1994
1995
›

Discover Tenders by Profile Sections Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Profile Sections Sector

Filter Your Search

FREE Trial plan for all new users!